AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

MediWound Ltd.

$13.11 -$5.31 (-28.83%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$13.71
Day Range
$12.95$13.81
Year Range
$12.52$20.03
Market Cap
168.41M
AVG Volume
93.32K
Trailing/Forward PE
-8.19/-
PEG ratio
-26.41
Dividend Yield
-
Next Earnings Date
2026-11-19
Primary Exchange
NASDAQUS
Revenue (USD)
02M4M6M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MDWD Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q23.09M
26 Q11.48M
25 Q41.87M
25 Q35.43M
25 Q25.71M
25 Q13.96M
24 Q45.84M
24 Q34.36M
24 Q25.06M
24 Q14.96M
Net Income (USD)
-15M-10M-5M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MDWD Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2-7.39M
26 Q1-2.95M
25 Q4-7.18M
25 Q3-2.65M
25 Q2-13.32M
25 Q1-726K
24 Q4-3.91M
24 Q3-10.28M
24 Q2-6.3M
24 Q1-9.73M
Operating Income (USD)
-10M-7.5M-5M-2.5M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MDWD Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2-9.46M
26 Q1-7.98M
25 Q4-7.81M
25 Q3-6.53M
25 Q2-5.72M
25 Q1-5.22M
24 Q4-6.08M
24 Q3-5.08M
24 Q2-4.48M
24 Q1-3.73M
EBITDA (USD)
-20M-15M-10M-5M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MDWD EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2-9.06M
26 Q1-2.59M
25 Q4-5.17M
25 Q3-2.18M
25 Q2-4.89M
25 Q1-363K
24 Q4-15.71M
24 Q3-4.72M
24 Q2-3.54M
24 Q1-3.37M
Cash Flows (USD)
-15M-10M-5M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MDWD Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q2-10.06M
26 Q1-8.57M
25 Q4-5.47M
25 Q3-4.28M
25 Q2-6.8M
25 Q1-5.07M
24 Q4-2.44M
24 Q3-4.95M
24 Q2-6.64M
24 Q1-5.26M
EPS (USD)
-1.5-1-0.5024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MDWD EPS (USD) by quarter
PeriodEPS (USD)
26 Q2-0.57
26 Q1-0.23
25 Q4-0.56
25 Q3-0.24
25 Q2-1.23
25 Q1-0.07
24 Q4-0.36
24 Q3-0.98
24 Q2-0.68
24 Q1-1.05
Expenses (USD)
05M10M15MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MDWD Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q210.86M
26 Q110.56M
25 Q410.26M
25 Q38.47M
25 Q28.11M
25 Q16.92M
24 Q47.56M
24 Q36.95M
24 Q27.95M
24 Q15.6M
Cash & Debt (USD)
020M40M60MCashShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MDWD Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q235.34M
26 Q144.65M
25 Q453.14M
25 Q359.09M
25 Q232.44M
25 Q138.27M
24 Q49.15M
24 Q345.56M
24 Q229.21M
24 Q135.57M
Debt ratios
-15-10-5051024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MDWD Debt ratios by quarter
PeriodDebt ratios
26 Q21.36
26 Q12.46
25 Q43.57
25 Q32.2
25 Q20.92
25 Q11.31
24 Q40.1
24 Q36.52
24 Q27.42
24 Q1-10.6
Margins
0%10%20%30%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MDWD Margins by quarter
PeriodMargins
26 Q210.9%
26 Q121.9%
25 Q414.89%
25 Q316.5%
25 Q223.51%
25 Q118.66%
24 Q415.46%
24 Q315.55%
24 Q28.83%
24 Q112.23%
Return on Capital
-80%-60%-40%-20%0%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MDWD Return on Capital by quarter
PeriodReturn on Capital
26 Q2-20.74%
26 Q1-7.13%
25 Q4-16.46%
25 Q3-5.29%
25 Q2-66.2%
25 Q1-2.32%
24 Q4-12.54%
24 Q3-30.03%
24 Q2-35.28%
24 Q1-41.94%
Shares Outstanding
05M10M15M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MDWD Shares Outstanding by quarter
PeriodShares Outstanding
26 Q212.88M
26 Q112.87M
25 Q412.83M
25 Q311.02M
25 Q210.84M
25 Q110.37M
24 Q410.79M
24 Q310.51M
24 Q29.28M
24 Q19.23M
Book Value Per Share (USD)
024624 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MDWD Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q22.77
26 Q13.22
25 Q43.4
25 Q34.55
25 Q21.86
25 Q13.02
24 Q42.89
24 Q33.26
24 Q21.93
24 Q12.51
Total Assets (USD)
025M50M75M100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MDWD Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q271.88M
26 Q179.98M
25 Q486.25M
25 Q394.42M
25 Q267M
25 Q169.02M
24 Q473.5M
24 Q374.73M
24 Q257.3M
24 Q162.38M
Employee Count
0501001502016201720182019202020212022202320242025
MDWD Employee Count by quarter
PeriodEmployee Count
2025121
2024111
202388
202273
202167
202065
201962
201861
201760
201654
PE Ratio
05101520med 5.26Aug 19Oct 19Dec 19Feb 20Apr 20Jun 20Jul 20
MDWD PE Ratio by quarter
PeriodPE Ratio
Jul 2016.15
Jul 2017.02
Jul 2015.12
Jul 2014.5
Jul 2013.88
Jun 2011.04
Jun 2011.21
Jun 207.91
Jun 208.59
May 208.45
May 208.32
May 2010.59
May 2010.81
May 2010.97
Apr 2010.42
Apr 2010.92
Apr 208.78
Apr 208.04
Mar 209.05
Mar 208.72
Mar 2011.57
Mar 2013.55
Feb 2015.2
Feb 204.26
Feb 204.25
Feb 204.29
Jan 204.33
Jan 204.36
Jan 204.33
Jan 204.33
Jan 204.36
Dec 194.32
Dec 194.34
Dec 194.43
Dec 194.09
Nov 194.28
Nov 194.29
Nov 194.36
Nov 195.01
Nov 194.88
Oct 194.65
Oct 194.68
Oct 194.98
Oct 195.03
Sep 195.15
Sep 195.51
Sep 195.36
Sep 195.08
Aug 195.26
Aug 195.03
Aug 194.53
Free Cash Flow Yield
-17.5%-15%-12.5%-10%-7.5%med -10.19%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
MDWD Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-16.81%
Sep 26-16.58%
Aug 26-17.4%
Aug 26-16.68%
Aug 26-16.25%
Aug 26-13.57%
Jul 26-13.82%
Jul 26-13.72%
Jul 26-13.36%
Jul 26-13.66%
Jul 26-12.88%
Jun 26-12.85%
Jun 26-13.71%
Jun 26-13.73%
Jun 26-13.77%
May 26-11.77%
May 26-10.17%
May 26-10.28%
May 26-10.18%
May 26-10.14%
Apr 26-10.08%
Apr 26-9.52%
Apr 26-9.45%
Apr 26-10.03%
Mar 26-11.2%
Mar 26-9.94%
Mar 26-10.17%
Mar 26-9.9%
Feb 26-9.75%
Feb 26-9.44%
Feb 26-9.77%
Feb 26-9.49%
Jan 26-9.31%
Jan 26-9.53%
Jan 26-10.38%
Jan 26-9.02%
Jan 26-9.16%
Dec 25-8.98%
Dec 25-8.99%
Dec 25-8.86%
Dec 25-9.54%
Nov 25-9.42%
Nov 25-9.89%
Nov 25-9.74%
Nov 25-10.13%
Oct 25-9.7%
Oct 25-9.64%
Oct 25-9.46%
Oct 25-9.79%
Oct 25-10.34%
Sep 25-9.94%
Sep 25-10.47%
Sep 25-9.97%
Sep 25-10.91%
Aug 25-10.65%
Aug 25-10.1%
Aug 25-9.82%
Aug 25-9.88%
Aug 25-9.94%
Jul 25-9.06%
Jul 25-9%
Jul 25-9.19%
Jul 25-9.52%
Jun 25-9.56%
Jun 25-9.65%
Jun 25-9.02%
Jun 25-8.52%
May 25-8.39%
May 25-9.04%
May 25-8.73%
May 25-10.2%
May 25-10.36%
Apr 25-9.89%
Apr 25-10.45%
Apr 25-10.92%
Apr 25-11.94%
Mar 25-11.21%
Mar 25-10.99%
Mar 25-10.67%
Mar 25-11.69%
Feb 25-11.92%
Feb 25-11.19%
Feb 25-10.55%
Feb 25-10.91%
Jan 25-10.11%
Jan 25-9.98%
Jan 25-11.22%
Jan 25-11.83%
Jan 25-11%
Dec 24-11.18%
Dec 24-12%
Dec 24-11.44%
Dec 24-11.66%
Nov 24-11.33%
Nov 24-13.59%
Nov 24-14%
Nov 24-12.96%
Nov 24-12.19%
Oct 24-12.82%
Oct 24-12.74%
Price to Sales
6810121416med 9.9Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
MDWD Price to Sales by quarter
PeriodPrice to Sales
Sep 2614.24
Sep 2614.43
Aug 2613.75
Aug 2614.35
Aug 2614.73
Aug 2612.79
Jul 2612.55
Jul 2612.65
Jul 2612.99
Jul 2612.71
Jul 2613.48
Jun 2613.51
Jun 2612.66
Jun 2612.64
Jun 2612.61
May 2610.84
May 2612.54
May 2612.41
May 2612.53
May 2612.58
Apr 2612.64
Apr 2613.4
Apr 2613.5
Apr 2612.71
Mar 2611.38
Mar 2612.83
Mar 2612.54
Mar 2612.88
Feb 269.11
Feb 269.41
Feb 269.09
Feb 269.37
Jan 269.55
Jan 269.32
Jan 268.56
Jan 269.85
Jan 269.7
Dec 259.89
Dec 259.88
Dec 2510.03
Dec 259.31
Nov 259.44
Nov 258.98
Nov 259.96
Nov 259.58
Oct 2510
Oct 2510.06
Oct 2510.26
Oct 259.91
Oct 259.38
Sep 259.76
Sep 259.26
Sep 259.73
Sep 258.89
Aug 259.11
Aug 259.61
Aug 259.88
Aug 2510.06
Aug 2510
Jul 2510.98
Jul 2511.05
Jul 2510.81
Jul 2510.44
Jun 2510.4
Jun 2510.31
Jun 2511.02
Jun 2511.66
May 2511.85
May 2511
May 2510.93
May 259.35
May 259.21
Apr 259.65
Apr 259.13
Apr 258.74
Apr 257.99
Mar 258.51
Mar 258.68
Mar 259.88
Mar 259.02
Feb 258.85
Feb 259.42
Feb 2510
Feb 259.66
Jan 2510.44
Jan 2510.57
Jan 259.4
Jan 258.91
Jan 259.59
Dec 249.43
Dec 248.79
Dec 249.22
Dec 249.05
Nov 249.31
Nov 247.59
Nov 247.37
Nov 247.97
Nov 248.46
Oct 248.05
Oct 248.1
EV/EBITDA
020406080med 5.63Sep 19Dec 19Feb 20May 20Jul 20May 24Aug 24
MDWD EV/EBITDA by quarter
PeriodEV/EBITDA
Aug 2453.53
Aug 2451.5
Jul 2459.74
Jul 2455.48
Jul 2464.58
Jul 2459.03
Jun 2444.54
Jun 2437.22
Jun 2442.62
Jun 2449.94
May 2447.34
May 2444.93
May 2447.04
May 2448.26
May 2453.01
Apr 2451.54
Apr 2442.72
Apr 2443.5
Apr 2440.36
Mar 2437.28
Mar 2443.43
Jul 2014.14
Jul 2015.14
Jul 2012.96
Jul 2012.25
Jul 2011.54
Jun 208.27
Jun 208.46
Jun 204.67
Jun 205.45
May 205.29
May 205.14
May 206
May 206.25
May 206.45
Apr 205.8
Apr 206.38
Apr 203.87
Apr 202.99
Mar 204.18
Mar 203.8
Mar 207.16
Mar 209.49
Feb 2011.43
Feb 203.91
Feb 203.88
Feb 203.95
Jan 204.01
Jan 204.05
Jan 204.01
Jan 204.01
Jan 204.05
Dec 193.99
Dec 194.02
Dec 194.16
Dec 193.65
Nov 193.93
Nov 193.95
Nov 194.05
Nov 193.42
Nov 193.25
Oct 192.96
Oct 193.01
Oct 193.38
Oct 193.44
Sep 193.59
Sep 194.04
Sep 193.85
Sep 193.5
Aug 193.73
Aug 193.44
Aug 192.82
Price/Operating Cashflow
57.51012.515med 7.38Aug 19Oct 19Dec 19Feb 20Apr 20Jun 20Jul 20
MDWD Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Jul 2013.66
Jul 2014.39
Jul 2012.78
Jul 2012.26
Jul 2011.74
Jun 209.34
Jun 209.47
Jun 206.69
Jun 207.27
May 207.14
May 207.04
May 206.75
May 206.89
May 207
Apr 206.65
Apr 206.96
Apr 205.6
Apr 205.13
Mar 205.77
Mar 205.56
Mar 207.38
Mar 208.64
Feb 209.69
Feb 209.39
Feb 209.36
Feb 209.45
Jan 209.54
Jan 209.61
Jan 209.54
Jan 209.54
Jan 209.61
Dec 199.51
Dec 199.55
Dec 199.76
Dec 199.01
Nov 199.42
Nov 199.45
Nov 199.61
Nov 196.75
Nov 196.57
Oct 196.25
Oct 196.3
Oct 196.7
Oct 196.77
Sep 196.94
Sep 197.42
Sep 197.22
Sep 196.84
Aug 197.08
Aug 196.77
Aug 196.1
Price to Book
24681012med 5.34Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
MDWD Price to Book by quarter
PeriodPrice to Book
Sep 264.74
Sep 264.8
Aug 264.58
Aug 264.77
Aug 264.9
Aug 264.47
Jul 264.39
Jul 264.42
Jul 264.54
Jul 264.44
Jul 264.71
Jun 264.72
Jun 264.43
Jun 264.42
Jun 264.41
May 264.21
May 264.87
May 264.82
May 264.87
May 264.89
Apr 264.91
Apr 265.21
Apr 265.25
Apr 264.94
Mar 264.42
Mar 264.99
Mar 264.87
Mar 265.01
Feb 263.8
Feb 263.93
Feb 263.8
Feb 263.91
Jan 263.98
Jan 263.89
Jan 263.57
Jan 264.11
Jan 264.05
Dec 254.13
Dec 254.12
Dec 254.19
Dec 253.89
Nov 253.94
Nov 253.75
Nov 259.83
Nov 259.46
Oct 259.87
Oct 259.93
Oct 2510.12
Oct 259.79
Oct 259.26
Sep 259.63
Sep 259.14
Sep 259.61
Sep 258.77
Aug 258.99
Aug 259.48
Aug 259.75
Aug 256.18
Aug 256.15
Jul 256.74
Jul 256.79
Jul 256.64
Jul 256.41
Jun 256.39
Jun 256.33
Jun 256.77
Jun 257.16
May 257.28
May 256.76
May 257.09
May 256.07
May 255.98
Apr 256.26
Apr 255.92
Apr 255.67
Apr 255.19
Mar 255.52
Mar 255.64
Mar 255.69
Mar 255.2
Feb 255.1
Feb 255.43
Feb 255.76
Feb 255.57
Jan 256.01
Jan 256.09
Jan 255.42
Jan 255.13
Jan 255.52
Dec 245.43
Dec 245.06
Dec 245.31
Dec 245.21
Nov 245.36
Nov 248.56
Nov 248.31
Nov 248.98
Nov 249.54
Oct 249.08
Oct 249.13
MediWound Ltd.
MDWD
Stockpicker

Video analysis: MDWD

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: MDWD

MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference

globenewswire.com · 2 Sep 2026

MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference

MediWound to Present at the H.C. Wainwright 28 th Annual Global Investment Conference YAVNE, Israel, September 2, 2026 -- MediWound Ltd.

MediWound Ltd. (MDWD) Q2 2026 Earnings Call Transcript

seekingalpha.com · 13 Aug 2026

MediWound Ltd. (MDWD) Q2 2026 Earnings Call Transcript

MediWound Ltd. (MDWD) Q2 2026 Earnings Call Transcript

MediWound Q2 Earnings Call Highlights

marketbeat.com · 13 Aug 2026

MediWound Q2 Earnings Call Highlights

MediWound NASDAQ: MDWD reported second-quarter 2026 revenue of $3.1 million, down from $5.7 million a year earlier, as the company continued investing in its Phase III EscharEx chronic-wound program and expanded development work around its NexoBrid burn treatment.

MediWound (MDWD) Reports Q2 Loss, Beats Revenue Estimates

zacks.com · 13 Aug 2026

MediWound (MDWD) Reports Q2 Loss, Beats Revenue Estimates

MediWound (MDWD) came out with a quarterly loss of $0.77 per share versus the Zacks Consensus Estimate of a loss of $0.76. This compares to a loss of $1.23 per share a year ago.

MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update

globenewswire.com · 13 Aug 2026

MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update

EscharEx ® Phase III VALUE Trial Advancing; Interim Assessment and Enrollment Completion Expected by End of First Quarter 2027 Master Services Agreement Signed with Vericel Under its BARDA Contract for NexoBrid ® Second Quarter Revenue of $3.1 Million; Full-Year 2026 Revenue Guidance of $24–26 Million Reaffirmed Conference Call Today at 8:30 a.m. Eastern Time YAVNE, Israel, Aug. 13, 2026 (GLOBE NEWSWIRE) -- MediWound Ltd.

MediWound to Report Second Quarter 2026 Financial Results

globenewswire.com · 29 Jul 2026

MediWound to Report Second Quarter 2026 Financial Results

MediWound to Report Second Quarter 2026 Financial Results Conference Call and Webcast Scheduled for Thursday, August 13 at 8:30 a.m. Eastern Time YAVNE, Israel, July 29, 2026 -- MediWound Ltd.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.